Literature DB >> 1268550

Rebound hypertension after acute methyldopa withdrawal.

A C Burden, C P Alexander.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1268550      PMCID： PMC1639897          DOI： 10.1136/bmj.1.6017.1056

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  1 in total

1.  Studies on catecholamines, renin and aldosterone following Catapresan (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patients.

Authors:  B Hökfelt; H Hedeland; J F Dymling
Journal:  Eur J Pharmacol       Date:  1970       Impact factor: 4.432
  1 in total
  4 in total

1.  Clonidine withdrawal-fact or fiction?

Authors:  M C Houston
Journal:  West J Med       Date:  1979-11

2.  Double-blind trial comparing guanfacine and methyldopa in patients with essential hypertension.

Authors:  A J Bune; J P Chalmers; J R Graham; P R Howe; M J West; L M Wing
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 3.  Adverse effects of antihypertensive drugs.

Authors:  F E Husserl; F H Messerli
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546

Review 4.  Clinical consequences of abrupt drug withdrawal.

Authors:  C F George; D Robertson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.